Preclinical Research in McArdle Disease: A Review of Research Models and Therapeutic Strategies
McArdle disease is an autosomal recessive disorder of muscle glycogen metabolism caused by pathogenic mutations in the <i>PYGM</i> gene, which encodes the skeletal muscle-specific isoform of glycogen phosphorylase. Clinical symptoms are mainly characterized by transient acute “crises” of...
Main Authors: | Mónica Villarreal-Salazar, Astrid Brull, Gisela Nogales-Gadea, Antoni L. Andreu, Miguel A. Martín, Joaquín Arenas, Alfredo Santalla, Alejandro Lucia, John Vissing, Thomas O. Krag, Tomàs Pinós |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/13/1/74 |
Similar Items
-
Sodium valproate increases the brain isoform of glycogen phosphorylase: looking for a compensation mechanism in McArdle disease using a mouse primary skeletal-muscle culture in vitro
by: Noemí de Luna, et al.
Published: (2015-05-01) -
Low aerobic capacity in McArdle disease: A role for mitochondrial network impairment?
by: M. Villarreal-Salazar, et al.
Published: (2022-12-01) -
Diagnosis and management of children with McArdle Syndrome (GSD V) in New South Wales
by: Louisa Adams, et al.
Published: (2023-09-01) -
Data from the European registry for patients with McArdle disease (EUROMAC): functional status and social participation
by: Walaa Karazi, et al.
Published: (2023-07-01) -
Creation and implementation of a European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC registry)
by: Tomàs Pinós, et al.
Published: (2020-10-01)